Kuo YM - Search Results

1

High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease.

Kuo YM, Emmerling MR, Lampert HC, Hempelman SR, Kokjohn TA, Woods AS, Cotter RJ, Roher AE. Kuo YM, et al. Biochem Biophys Res Commun. 1999 Apr 21;257(3):787-91. doi: 10.1006/bbrc.1999.0552. Biochem Biophys Res Commun. 1999. PMID: 10208861

2

APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques.

Kalback W, Watson MD, Kokjohn TA, Kuo YM, Weiss N, Luehrs DC, Lopez J, Brune D, Sisodia SS, Staufenbiel M, Emmerling M, Roher AE. Kalback W, et al. Among authors: kuo ym. Biochemistry. 2002 Jan 22;41(3):922-8. doi: 10.1021/bi015685+. Biochemistry. 2002. PMID: 11790115

3

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, Roher AE. Kuo YM, et al. J Biol Chem. 1996 Feb 23;271(8):4077-81. doi: 10.1074/jbc.271.8.4077. J Biol Chem. 1996. PMID: 8626743 Free article.

4

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

Roher AE, Chaney MO, Kuo YM, Webster SD, Stine WB, Haverkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, Bonnell BS, Emmerling MR. Roher AE, et al. Among authors: kuo ym. J Biol Chem. 1996 Aug 23;271(34):20631-5. doi: 10.1074/jbc.271.34.20631. J Biol Chem. 1996. PMID: 8702810 Free article.

5

Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits.

Kuo YM, Emmerling MR, Woods AS, Cotter RJ, Roher AE. Kuo YM, et al. Biochem Biophys Res Commun. 1997 Aug 8;237(1):188-91. doi: 10.1006/bbrc.1997.7083. Biochem Biophys Res Commun. 1997. PMID: 9266855 Free article.

6

Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease.

Kuo YM, Webster S, Emmerling MR, De Lima N, Roher AE. Kuo YM, et al. Biochim Biophys Acta. 1998 Apr 28;1406(3):291-8. doi: 10.1016/s0925-4439(98)00014-3. Biochim Biophys Acta. 1998. PMID: 9630681 Free article.

7

Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.

Kuo YM, Emmerling MR, Bisgaier CL, Essenburg AD, Lampert HC, Drumm D, Roher AE. Kuo YM, et al. Biochem Biophys Res Commun. 1998 Nov 27;252(3):711-5. doi: 10.1006/bbrc.1998.9652. Biochem Biophys Res Commun. 1998. PMID: 9837771

8

Amyloid and lipids in the pathology of Alzheimer disease.

Roher AE, Kuo YM, Kokjohn KM, Emmerling MR, Gracon S. Roher AE, et al. Among authors: kuo ym. Amyloid. 1999 Jun;6(2):136-45. doi: 10.3109/13506129909007315. Amyloid. 1999. PMID: 10439121 Review. No abstract available.

9

Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma.

Kuo YM, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Koo EH, Emmerling MR, Roher AE. Kuo YM, et al. Biochem Biophys Res Commun. 2000 Feb 24;268(3):750-6. doi: 10.1006/bbrc.2000.2222. Biochem Biophys Res Commun. 2000. PMID: 10679277

10

Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism.

Kuo YM, Kokjohn TA, Watson MD, Woods AS, Cotter RJ, Sue LI, Kalback WM, Emmerling MR, Beach TG, Roher AE. Kuo YM, et al. Am J Pathol. 2000 Mar;156(3):797-805. doi: 10.1016/s0002-9440(10)64947-4. Am J Pathol. 2000. PMID: 10702395 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters